Back to List View Graph View

Cellular senescence

Cellular senescence is a stable cell-state program in which cells undergo essentially irreversible growth arrest while remaining metabolically active.

Where the papers sit

9 papers from the last 6 months study cellular senescence directly · updated from PubMed 12 Nov 2026

Study type 0 clinical trials · 1 observational · 7 preclinical · 1 unclassified

Themes no clear themes

Those 9 do not share a common subject.

  • Cellular senescence is examined across MASH, neurodegeneration, periodontitis, obesity, pulmonary fibrosis and biological ageing. Proposed interventions include navitoclax delivery, uPAR-targeted nanoparticles, IGFBP5, SIRT1 activity and synthetic small molecules. The studies differ in mechanisms, tissues and outcomes, with no shared therapeutic strategy or consistent direction. Their common thread is exploratory interest in senescence as a marker or target of diverse age-related disease.

    9 papers

Papers

The 9 papers from the last 6 months that study cellular senescence directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

No clear themes (9)
  1. Validation of senescence as a therapeutic target in metabolic dysfunction-associated steatohepatitis (MASH) through navitoclax delivery. Journal of controlled release : official journal of the Controlled Release Society · 2 Nov 2026 PMID 42971435
  2. Cellular senescence is an early feature and therapeutic target in amyotrophic lateral sclerosis TDP-43Q331K mice. Neurobiology of disease · 18 Sept 2026 PMID 42759848
  3. IGFBP5 alleviates periodontitis by reversing human dental follicle stem cell senescence via the non-canonical Wnt pathway. International journal of oral science · 14 Sept 2026 PMID 42736271
  4. The Senescent Phenotype of Cultured Hypothalamic Astrocytes from Rats with Streptozotocin-Induced Dementia. Neurochemical research · 11 Sept 2026 PMID 42726406
  5. SIRT1 Silences L1 Retrotransposons by Stabilizing Heterochromatin-Modifying Complexes. Aging cell · 30 Aug 2026 PMID 42669067
  6. Enhancing insulin sensitivity by reducing adipocyte senescence using uPAR-targeted nanoparticles in high-fat-diet-induced obese mice. Journal of controlled release : official journal of the Controlled Release Society · 13 Jul 2026 PMID 42442548
  7. Discovery of Novel Synthetic Cyclohexene-Based Small Molecules Targeting Senescence against Age-Related Pulmonary Fibrosis. Journal of medicinal chemistry · 10 Jul 2026 PMID 42427232
  8. Advance RI-CTR: Advancing a Decade of Discovery for Clinical & Translational Research in Rhode Island. Rhode Island medical journal (2013) · 25 Jun 2026 PMID 42348621
  9. Supplements and Drugs Are Associated With Biological Age in a Cohort of Exceptionally Healthy Individuals. Aging cell · 21 May 2026 PMID 42166733

By study type

Observational studies and case reports (1)
  1. Supplements and Drugs Are Associated With Biological Age in a Cohort of Exceptionally Healthy Individuals. Aging cell · 21 May 2026 PMID 42166733
Preclinical: animal, cell and lab studies (7)
  1. Cellular senescence is an early feature and therapeutic target in amyotrophic lateral sclerosis TDP-43Q331K mice. Neurobiology of disease · 18 Sept 2026 PMID 42759848
  2. IGFBP5 alleviates periodontitis by reversing human dental follicle stem cell senescence via the non-canonical Wnt pathway. International journal of oral science · 14 Sept 2026 PMID 42736271
  3. The Senescent Phenotype of Cultured Hypothalamic Astrocytes from Rats with Streptozotocin-Induced Dementia. Neurochemical research · 11 Sept 2026 PMID 42726406
  4. SIRT1 Silences L1 Retrotransposons by Stabilizing Heterochromatin-Modifying Complexes. Aging cell · 30 Aug 2026 PMID 42669067
  5. Enhancing insulin sensitivity by reducing adipocyte senescence using uPAR-targeted nanoparticles in high-fat-diet-induced obese mice. Journal of controlled release : official journal of the Controlled Release Society · 13 Jul 2026 PMID 42442548
  6. Discovery of Novel Synthetic Cyclohexene-Based Small Molecules Targeting Senescence against Age-Related Pulmonary Fibrosis. Journal of medicinal chemistry · 10 Jul 2026 PMID 42427232
  7. Advance RI-CTR: Advancing a Decade of Discovery for Clinical & Translational Research in Rhode Island. Rhode Island medical journal (2013) · 25 Jun 2026 PMID 42348621
Unclassified: not yet indexed with MeSH (1)
  1. Validation of senescence as a therapeutic target in metabolic dysfunction-associated steatohepatitis (MASH) through navitoclax delivery. Journal of controlled release : official journal of the Controlled Release Society · 2 Nov 2026 PMID 42971435